{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:36:07Z","timestamp":1792859767335,"version":"4.5.0"},"reference-count":61,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270404"],"award-info":[{"award-number":["82270404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570461"],"award-info":[{"award-number":["82570461"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300421"],"award-info":[{"award-number":["82300421"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300422"],"award-info":[{"award-number":["82300422"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400451"],"award-info":[{"award-number":["82400451"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400445"],"award-info":[{"award-number":["82400445"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD0547701"],"award-info":[{"award-number":["2025ZD0547701"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Sailing Program of Science and Technology Commission","award":["23YF14360000"],"award-info":[{"award-number":["23YF14360000"]}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Program","award":["202540150"],"award-info":[{"award-number":["202540150"]}]},{"name":"Clinical Research Program","award":["20254Y0151"],"award-info":[{"award-number":["20254Y0151"]}]},{"DOI":"10.13039\/100007219","name":"Shanghai Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"name":"of Science and Technology Commission","award":["24ZR1448700"],"award-info":[{"award-number":["24ZR1448700"]}]},{"name":"Huangpu District Key Medical Discipline Program","award":["2025ZDXK01"],"award-info":[{"award-number":["2025ZDXK01"]}]},{"name":"Huangpu Special Studio Program","award":["2023MY01"],"award-info":[{"award-number":["2023MY01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Transthyretin (TTR) amyloid cardiomyopathy (ATTR-CM) is a progressive cause of heart failure, especially in the ageing society, but cellular biological mechanism studies are limited by the lack of robust animal models. Vitronectin (VTN), an extracellular matrix (ECM) glycoprotein enriched in amyloid deposits, may contribute to amyloidogenesis, yet its pathogenic role in ATTR-CM remains undefined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Humanized knock-in mice expressing either wild-type (hTTRWT) or V142I mutant transthyretin (hTTRV142I) were generated. Amyloid burden, cardiac structure, and function were assessed by Congo red staining, electron microscopy, echocardiography, and cardiac magnetic resonance. The functional role of VTN and integrin signalling was studied using genetic silencing and pharmacological intervention with low-dose cilengitide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Both hTTRWT and hTTRV142I mice developed age-dependent cardiac amyloidosis with diastolic dysfunction and reduced survival, especially in the hTTRV142I strain. VTN co-localized with TTR fibrils, promoted fibril aggregation, reduced amyloid burden upon its knockdown, and preserved cardiac function. Mechanistically, TTR amyloid suppressed integrin \u03b1v\u03b23\/FAK\/Akt signalling, leading to marked mitochondrial dysregulation characterized by excessive fission, enhanced mitophagy, and impaired oxidative phosphorylation. Restoration of \u03b1v\u03b23 signalling with cilengitide normalized mitochondrial dynamics, improved bioenergetics, and ameliorated diastolic dysfunction despite persistent amyloid stress.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Two reproducible ATTR-CM models that recapitulate the steadily progressive course of human disease were established. Furthermore, VTN actively drives cardiac amyloid deposition, and disruption of integrin \u03b1v\u03b23\/FAK\/Akt signalling links amyloid\u2013ECM interactions to mitochondrial dysfunction. Therefore, modulation of integrin signalling represents a potential complementary therapeutic strategy in ATTR-CM beyond TTR suppression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehag598","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:58:00Z","timestamp":1784721480000},"source":"Crossref","is-referenced-by-count":2,"title":["Vitronectin-driven amyloid deposition disrupts mitochondrial homeostasis via integrin-mediated pathway in a humanized mouse model of transthyretin cardiac amyloidosis"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0197-7502","authenticated-orcid":false,"given":"Zeping","family":"Qiu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , 197 Ruijin 2nd Road, Shanghai 200025 ,","place":["PR China"]},{"name":"Heart Failure Center, Ruijin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, 149 S.Chongging Road , Shanghai 200020, PR \u00a0","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingze","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , 197 Ruijin 2nd Road, Shanghai 200025 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Center Utrecht , Utrecht ,","place":["The Netherlands"]},{"name":"Laboratory of Experimental Cardiology, Regenerative Medicine Center Utrecht, Circulatory Health Research Center, University Utrecht, University Medical Center Utrecht , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haikun","family":"Qi","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfang","family":"Miao","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , 197 Ruijin 2nd Road, Shanghai 200025 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , 197 Ruijin 2nd Road, Shanghai 200025 ,","place":["PR China"]},{"name":"Heart Failure Center, Ruijin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, 149 S.Chongging Road , Shanghai 200020, PR \u00a0","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , 197 Ruijin 2nd Road, Shanghai 200025 ,","place":["PR China"]},{"name":"Heart Failure Center, Ruijin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, 149 S.Chongging Road , Shanghai 200020, PR \u00a0","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , 197 Ruijin 2nd Road, Shanghai 200025 ,","place":["PR China"]},{"name":"Heart Failure Center, Ruijin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, 149 S.Chongging Road , Shanghai 200020, PR \u00a0","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , 197 Ruijin 2nd Road, Shanghai 200025 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , 197 Ruijin 2nd Road, Shanghai 200025 ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Hua","sequence":"additional","affiliation":[{"name":"Heart Failure Center, Ruijin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, 149 S.Chongging Road , Shanghai 200020, PR \u00a0","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marish I F J","family":"Oerlemans","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Center Utrecht , Utrecht ,","place":["The Netherlands"]},{"name":"Laboratory of Experimental Cardiology, Regenerative Medicine Center Utrecht, Circulatory Health Research Center, University Utrecht, University Medical Center Utrecht , Utrecht ,","place":["The Netherlands"]},{"name":"European Reference Network for Rare, low Prevalence and complex Diseases of the Heart (ERN GUARD-Heart) , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9906-5047","authenticated-orcid":false,"given":"Alain","family":"van Mil","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Center Utrecht , Utrecht ,","place":["The Netherlands"]},{"name":"Laboratory of Experimental Cardiology, Regenerative Medicine Center Utrecht, Circulatory Health Research Center, University Utrecht, University Medical Center Utrecht , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2905-2109","authenticated-orcid":false,"given":"Wei","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , 197 Ruijin 2nd Road, Shanghai 200025 ,","place":["PR China"]},{"name":"Heart Failure Center, Ruijin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, 149 S.Chongging Road , Shanghai 200020, PR \u00a0","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"2026081110424903700_ehag598-B1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ejhf.2140","article-title":"Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026081110424903700_ehag598-B2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12471-019-1299-1","article-title":"Cardiac amyloidosis: the need for early diagnosis","volume":"27","author":"Oerlemans","year":"2019","journal-title":"Neth Heart J"},{"key":"2026081110424903700_ehag598-B3","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/ejhf.2532","article-title":"Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies","volume":"24","author":"Aimo","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026081110424903700_ehag598-B4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","article-title":"Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ Heart Fail"},{"key":"2026081110424903700_ehag598-B5","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1001\/jamacardio.2025.2948","article-title":"Transthyretin cardiac amyloidosis in older Black and Hispanic individuals with heart failure","volume":"10","author":"Ruberg","year":"2025","journal-title":"JAMA Cardiol"},{"key":"2026081110424903700_ehag598-B6","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/ejhf.3339","article-title":"Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis","volume":"26","author":"Muller","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026081110424903700_ehag598-B7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/gim.2016.200","article-title":"Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans","volume":"19","author":"Buxbaum","year":"2017","journal-title":"Genet Med"},{"key":"2026081110424903700_ehag598-B8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","article-title":"The extracellular matrix in ischemic and nonischemic heart failure","volume":"125","author":"Frangogiannis","year":"2019","journal-title":"Circ Res"},{"key":"2026081110424903700_ehag598-B9","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.121.055732","article-title":"Extracellular matrix in heart failure: role of ADAMTS5 in proteoglycan remodeling","volume":"144","author":"Barallobre-Barreiro","year":"2021","journal-title":"Circulation"},{"key":"2026081110424903700_ehag598-B10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1161\/CIRCRESAHA.123.323365","article-title":"Sox9 accelerates vascular aging by regulating extracellular matrix composition and stiffness","volume":"134","author":"Faleeva","year":"2024","journal-title":"Circ Res"},{"key":"2026081110424903700_ehag598-B11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cca.2005.12.015","article-title":"Vitronectin in atherosclerotic disease","volume":"368","author":"Ekmekci","year":"2006","journal-title":"Clin Chim Acta"},{"key":"2026081110424903700_ehag598-B12","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1369\/0022155415595264","article-title":"MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits","volume":"63","author":"Winter","year":"2015","journal-title":"J Histochem Cytochem"},{"key":"2026081110424903700_ehag598-B13","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jaccao.2020.08.013","article-title":"A proteomic atlas of cardiac amyloid plaques","volume":"2","author":"Kourelis","year":"2020","journal-title":"JACC CardioOncol"},{"key":"2026081110424903700_ehag598-B14","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.jcyt.2017.08.021","article-title":"Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damage","volume":"19","author":"Lin","year":"2017","journal-title":"Cytotherapy"},{"key":"2026081110424903700_ehag598-B15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10787","article-title":"Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity","volume":"7","author":"Sant'Anna","year":"2016","journal-title":"Nat Commun"},{"key":"2026081110424903700_ehag598-B16","doi-asserted-by":"publisher","first-page":"9992","DOI":"10.1073\/pnas.1300761110","article-title":"AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin","volume":"110","author":"Penchala","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026081110424903700_ehag598-B17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s13287-025-04464-6","article-title":"Uncovering cell type-specific phenotypes using a novel human in vitro model of transthyretin amyloid cardiomyopathy","volume":"16","author":"Qin","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"2026081110424903700_ehag598-B18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/13506129.2023.2224494","article-title":"Mapping cellular response to destabilized transthyretin reveals cell- and amyloidogenic protein-specific signatures","volume":"30","author":"Ghosh","year":"2023","journal-title":"Amyloid"},{"key":"2026081110424903700_ehag598-B19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.stemcr.2013.10.003","article-title":"Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosis","volume":"1","author":"Leung","year":"2013","journal-title":"Stem Cell Reports"},{"key":"2026081110424903700_ehag598-B20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.020358","article-title":"Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis","volume":"10","author":"Pucci","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026081110424903700_ehag598-B21","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1093\/cvr\/cvaf152","article-title":"In vitro and in vivo disease models of cardiac amyloidosis: progress, pitfalls, and potential","volume":"121","author":"Qin","year":"2025","journal-title":"Cardiovasc Res"},{"key":"2026081110424903700_ehag598-B22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/labinvest.3780246","article-title":"Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis","volume":"81","author":"Teng","year":"2001","journal-title":"Lab Invest"},{"key":"2026081110424903700_ehag598-B23","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/S0002-9440(10)64469-0","article-title":"Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro","volume":"161","author":"Sousa","year":"2002","journal-title":"Am J Pathol"},{"key":"2026081110424903700_ehag598-B24","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41374-017-0019-y","article-title":"Amyloid deposition in a mouse model humanized at the transthyretin and retinol-binding protein 4 loci","volume":"98","author":"Li","year":"2018","journal-title":"Lab Invest"},{"key":"2026081110424903700_ehag598-B25","doi-asserted-by":"publisher","first-page":"7112","DOI":"10.1038\/s41467-021-27416-z","article-title":"Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis","volume":"12","author":"Slamova","year":"2021","journal-title":"Nat Commun"},{"key":"2026081110424903700_ehag598-B26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa1404852","article-title":"The amyloidogenic V122I transthyretin variant in elderly Black Americans","volume":"372","author":"Quarta","year":"2015","journal-title":"N Engl J Med"},{"key":"2026081110424903700_ehag598-B27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/13506129.2022.2127088","article-title":"Subtyping of cardiac amyloidosis by mass spectrometry-based proteomics of endomyocardial biopsies","volume":"30","author":"Noborn","year":"2023","journal-title":"Amyloid"},{"key":"2026081110424903700_ehag598-B28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41580-019-0134-2","article-title":"Integrins as biomechanical sensors of the microenvironment","volume":"20","author":"Kechagia","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026081110424903700_ehag598-B29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ccell.2018.11.016","article-title":"Tinagl1 suppresses triple-negative breast cancer progression and metastasis by simultaneously inhibiting integrin\/FAK and EGFR signaling","volume":"35","author":"Shen","year":"2019","journal-title":"Cancer Cell"},{"key":"2026081110424903700_ehag598-B30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1126\/science.1069040","article-title":"Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an arg-gly-asp ligand","volume":"296","author":"Xiong","year":"2002","journal-title":"Science"},{"key":"2026081110424903700_ehag598-B31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nm.1941","article-title":"Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors","volume":"15","author":"Reynolds","year":"2009","journal-title":"Nat Med"},{"key":"2026081110424903700_ehag598-B32","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"2026081110424903700_ehag598-B33","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1056\/NEJMoa2300757","article-title":"Patisiran treatment in patients with transthyretin cardiac amyloidosis","volume":"389","author":"Maurer","year":"2023","journal-title":"N Engl J Med"},{"key":"2026081110424903700_ehag598-B34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa2409134","article-title":"Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","volume":"392","author":"Fontana","year":"2025","journal-title":"N Engl J Med"},{"key":"2026081110424903700_ehag598-B35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N Engl J Med"},{"key":"2026081110424903700_ehag598-B36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jacc.2025.04.055","article-title":"Impact of vutrisiran on cardiac biomarkers in patients with transthyretin amyloidosis with cardiomyopathy from HELIOS-B","volume":"86","author":"Maurer Mathew","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026081110424903700_ehag598-B37","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jacc.2023.12.036","article-title":"Stratifying disease progression in patients with cardiac ATTR amyloidosis","volume":"83","author":"Ioannou","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026081110424903700_ehag598-B38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/eurheartj\/ehaf667","article-title":"Transthyretin amyloid cardiomyopathy: from cause to novel treatments","volume":"47","author":"Fontana","year":"2026","journal-title":"Eur Heart J"},{"key":"2026081110424903700_ehag598-B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2023.103215","article-title":"Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation","volume":"72","author":"Bonilauri","year":"2023","journal-title":"Stem Cell Res"},{"key":"2026081110424903700_ehag598-B40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/13506129.2018.1489228","article-title":"A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeutics","volume":"25","author":"Giadone","year":"2018","journal-title":"Amyloid"},{"key":"2026081110424903700_ehag598-B41","doi-asserted-by":"publisher","first-page":"7365","DOI":"10.1021\/bi049621l","article-title":"Transthyretin aggregation under partially denaturing conditions is a downhill polymerization","volume":"43","author":"Hurshman","year":"2004","journal-title":"Biochemistry"},{"key":"2026081110424903700_ehag598-B42","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1074\/jbc.M708028200","article-title":"Human-murine transthyretin heterotetramers are kinetically stable and non-amyloidogenic. A lesson in the generation of transgenic models of diseases involving oligomeric proteins","volume":"283","author":"Reixach","year":"2008","journal-title":"J Biol Chem"},{"key":"2026081110424903700_ehag598-B43","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neurobiolaging.2008.04.001","article-title":"The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems","volume":"31","author":"Santos","year":"2010","journal-title":"Neurobiol Aging"},{"key":"2026081110424903700_ehag598-B44","doi-asserted-by":"publisher","first-page":"E6741","DOI":"10.1073\/pnas.1805131115","article-title":"Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition","volume":"115","author":"Saelices","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026081110424903700_ehag598-B45","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1007\/s10741-022-10237-7","article-title":"Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis","volume":"27","author":"Morfino","year":"2022","journal-title":"Heart Fail Rev"},{"key":"2026081110424903700_ehag598-B46","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1161\/CIRCULATIONAHA.122.060852","article-title":"Impact of earlier diagnosis in cardiac ATTR amyloidosis over the course of 20 years","volume":"146","author":"Ioannou","year":"2022","journal-title":"Circulation"},{"key":"2026081110424903700_ehag598-B47","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102183","article-title":"Proteostasis disturbances and inflammation in neurodegenerative diseases","volume":"9","author":"Sonninen","year":"2020","journal-title":"Cells"},{"key":"2026081110424903700_ehag598-B48","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.redox.2017.07.008","article-title":"Proteostasis, oxidative stress and aging","volume":"13","author":"Korovila","year":"2017","journal-title":"Redox Biol"},{"key":"2026081110424903700_ehag598-B49","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/s0008-6363(01)00547-8","article-title":"Vitronectin is up-regulated after vascular injury and vitronectin blockade prevents neointima formation","volume":"53","author":"Dufourcq","year":"2002","journal-title":"Cardiovasc Res"},{"key":"2026081110424903700_ehag598-B50","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/01.atv.18.2.168","article-title":"Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque","volume":"18","author":"Dufourcq","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026081110424903700_ehag598-B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.585108","article-title":"Soluble membrane attack complex: biochemistry and immunobiology","volume":"11","author":"Barnum","year":"2020","journal-title":"Front Immunol"},{"key":"2026081110424903700_ehag598-B52","doi-asserted-by":"publisher","first-page":"19788","DOI":"10.1074\/jbc.M908079199","article-title":"Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin","volume":"275","author":"Podor","year":"2000","journal-title":"J Biol Chem"},{"key":"2026081110424903700_ehag598-B53","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.1016\/j.cell.2025.06.047","article-title":"Comprehensive human proteome profiles across a 50-year lifespan reveal aging trajectories and signatures","volume":"188","author":"Ding","year":"2025","journal-title":"Cell"},{"key":"2026081110424903700_ehag598-B54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012387","article-title":"Role of vitronectin and its receptors in neuronal function and neurodegenerative diseases","volume":"23","author":"Ruzha","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026081110424903700_ehag598-B55","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.jcmg.2019.06.031","article-title":"Myocardial T1 and ECV measurement: underlying concepts and technical considerations","volume":"12","author":"Robinson","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026081110424903700_ehag598-B56","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12968-020-00699-9","article-title":"Electrocardiogram-less, free-breathing myocardial extracellular volume fraction mapping in small animals at high heart rates using motion-resolved cardiovascular magnetic resonance multitasking: a feasibility study in a heart failure with preserved ejection fraction rat model","volume":"23","author":"Han","year":"2021","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026081110424903700_ehag598-B57","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10214868","article-title":"Prognostic value of N-terminal pro-brain natriuretic peptide and high-sensitivity troponin T levels in the natural history of transthyretin amyloid cardiomyopathy and their evolution after tafamidis treatment","volume":"10","author":"Oghina","year":"2021","journal-title":"J Clin Med"},{"key":"2026081110424903700_ehag598-B58","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S1470-2045(14)70379-1","article-title":"Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial","volume":"15","author":"Stupp","year":"2014","journal-title":"Lancet Oncol"},{"key":"2026081110424903700_ehag598-B59","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/annonc\/mdv219","article-title":"Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)","volume":"26","author":"Vansteenkiste","year":"2015","journal-title":"Ann Oncol"},{"key":"2026081110424903700_ehag598-B60","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15207","article-title":"Transthyretin deposition alters cardiomyocyte sarcomeric architecture, calcium transients, and contractile force","volume":"10","author":"Dittloff","year":"2022","journal-title":"Physiol Rep"},{"key":"2026081110424903700_ehag598-B61","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","article-title":"Integrins in cancer: biological implications and therapeutic opportunities","volume":"10","author":"Desgrosellier","year":"2010","journal-title":"Nat Rev Cancer"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag598\/70611419\/ehag598.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag598\/70611419\/ehag598.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:44:47Z","timestamp":1786463087000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/10.1093\/eurheartj\/ehag598\/8758975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":61,"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag598","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"article-number":"ehag598"}}